STEVE GORLIN - 09 Nov 2023 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role: Director
Signature: /S/ STEVE GORLIN
Issuer symbol: BIVI
Transactions as of: 09 Nov 2023
Net transactions value: -$127,899
Form type: 4
Filing time: 06 Dec 2023, 16:16:27 UTC
Previous filing: 07 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIVI	Common Stock	Award	$0	+46,358	+61%	$0.000000	122,038	09 Nov 2023	Direct	F1
transaction	BIVI	Common Stock	Sale	$127,899	-75,680	-62%	$1.69	46,358	01 Dec 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.

Content

The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.